# clm_23C6088E7F70

subject: Abbott Laboratories (/record/abbott-laboratories.md)  
predicate: quarterly_operating_income  
value: 1,859,000,000 United States dollar  
valid_from: 2024-09-30  
valid_to: 2025-03-31  
published: 2024-10-31  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_75BE91C87765  
last_updated: 2026-11-08  
cite: AsOf. "Abbott Laboratories quarterly operating income: 1,859,000,000 United States dollar", as of 2024-09-30 (until 2025-03-31). Claim clm_23C6088E7F70, https://asof.is/claim/clm_23C6088E7F70, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1800/000162828024044602/0001628280-24-044602-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2024, filed 2024-10-31  

## Sources

- https://www.sec.gov/Archives/edgar/data/1800/000162828024044602/0001628280-24-044602-index.htm (primary, SEC EDGAR 10-Q Q3 FY2024, published 2024-10-31)

## Supersedes

- [Abbott Laboratories](/record/abbott-laboratories.md) | quarterly_operating_income | 1,669,000,000 United States dollar | valid 2024-06-30 to 2024-09-30 | conf 0.95 | superseded | superseded_by [clm_23C6088E7F70](/claim/clm_23C6088E7F70.md) | [clm_D714148AE67A](/claim/clm_D714148AE67A.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.